$CNCE CONCERT PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CONCERT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CONCERT PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CONCERT PHARMACEUTICALS, INC. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Adage Capital Partners, L.P. | 10% Owner | 510,147 | 4,565,816 | Feb 20 2014 | |||
| ALDRICH RICHARD | Director | 342,100 | 3,061,795 | Jun 11 2021 | |||
| ALDRICH RICHARD | Director | 82,405 | 737,525 | Oct 21 2014 | |||
| Auchincloss Thomas G | Director | 6,500 | 58,175 | Jun 12 2020 | |||
| Auchincloss Thomas G | Director | 0 | 0 | Dec 12 2014 | |||
| Barrett Ronald W | Director | 5,125 | 45,869 | Jun 11 2021 | |||
| BECKER MARC | CFO, PFO | 0 | 0 | Jan 08 2018 | |||
| Becker Marc A. | Chief Financial Officer | 71,371 | 638,770 | Feb 17 2021 | |||
| BROOKSIDE CAPITAL MANAGEMENT LLC | 10% Owner | 1,497,833 | 13,405,605 | Feb 21 2014 | |||
| BVF PARTNERS L P/IL | 10% Owner | 1,178,904 | 10,551,191 | Jun 12 2019 | |||
| Cassella James V | Chief Development Officer | 94,064 | 841,873 | Feb 17 2021 | |||
| Daws D. Ryan | Chief Financial Officer | 0 | 0 | Jan 06 2017 | |||
| Fitzgerald Meghan | Director | 0 | 0 | Jun 18 2018 | |||
| Flagship Ventures Fund 2004 L P | 10% Owner | 656,490 | 5,875,586 | Feb 19 2014 | |||
| Freund John Gordon | Director | 1,208,920 | 10,819,834 | Feb 21 2014 | |||
| GLAXOSMITHKLINE PLC | 1,356,533 | 12,140,970 | Feb 20 2014 | ||||
| Greylock XII GP LLC | 10% Owner | 67,256 | 601,941 | Feb 19 2014 | |||
| HERSCHA LYNETTE | General Counsel | 46,318 | 414,546 | Apr 03 2018 | |||
| Hoiland Jesper | Director | 5,125 | 45,869 | Jun 11 2021 | |||
| HUTT PETER BARTON | Director | 7,963 | 71,269 | Sep 01 2020 | |||
| HUTT PETER BARTON | Director | 4,424 | 39,595 | Feb 19 2014 | |||
| JAEGER WILFRED E | Director | 0 | 0 | Jun 12 2020 | |||
| Lynch Ryan | PAO | 18,059 | 161,628 | Aug 19 2019 | |||
| McGowan Pauline | VP, Finance | 0 | 0 | Jan 08 2016 | |||
| Munsie Jeffrey A | Chief Legal Officer | 46,153 | 413,069 | Feb 17 2021 | |||
| New Leaf Ventures I, L.P. | 10% Owner | 107,327 | 960,577 | Feb 21 2014 | |||
| QVT Associates GP LLC | 10% Owner | 559,999 | 5,011,991 | Feb 21 2014 | |||
| SCHUHSLER HELMUT | Director | 0 | 0 | Jun 15 2015 | |||
| Silverman Robert | Senior VP, General Counsel | 40,912 | 366,162 | Mar 13 2017 | |||
| Skyline Venture Partners Qualified Purchaser Fund IV L P | 10% Owner | 1,208,920 | 10,819,834 | Feb 21 2014 | |||
| Stuart Nancy | Chief Operating Officer | 173,280 | 1,550,856 | Feb 17 2021 | |||
| THREE ARCH MANAGEMENT III LLC | Director | 29,052 | 260,015 | Nov 20 2014 | |||
| Three Arch Management IV, L.L.C. | Director | 12,301 | 110,094 | Nov 20 2014 | |||
| Tung Roger D | Chief Executive Officer | 808,578 | 7,236,773 | Feb 17 2021 | |||
| TVM Life Science Ventures VI GmbH & Co KG | Director | 378,703 | 3,389,392 | Feb 20 2014 | |||
| van Heek Christi | Director | 5,000 | 44,750 | Jun 12 2020 | |||
| WIERENGA WENDALL | Director | 0 | 0 | Mar 17 2014 | |||
| WIERENGA WENDALL D | Director | 0 | 0 | Jun 18 2018 |